These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11604625)

  • 21. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolongation of skin allograft survival after neonatal injection of donor bone marrow and epidermal cells.
    Petit F; Minns AB; Nazzal JA; Hettiaratchy SP; Lantieri LA; Randolph MA; Lee WP
    Plast Reconstr Surg; 2004 Jan; 113(1):270-6. PubMed ID: 14707646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment.
    Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M
    Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induced pluripotent stem cell-derived mesenchymal stem cells prolong hind limb survival in a rat vascularized composite allotransplantation model.
    Mitsuzawa S; Ikeguchi R; Aoyama T; Ando M; Takeuchi H; Yurie H; Oda H; Noguchi T; Ohta S; Zhao C; Ikeya M; Matsuda S
    Microsurgery; 2019 Nov; 39(8):737-747. PubMed ID: 31471984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitomycin-C-treated peripheral blood mononuclear cells (PBMCs) prolong allograft survival in composite tissue allotransplantation.
    Radu CA; Kiefer J; Horn D; Kleist C; Dittmar L; Sandra F; Rebel M; Ryssel H; Koellensperger E; Gebhard MM; Lehnhardt M; Germann G; Terness P
    J Surg Res; 2012 Aug; 176(2):e95-e101. PubMed ID: 22445458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascularized bone marrow allotransplantation and low-dose cyclosporine prolong the survival of adipose tissue allografts.
    Hsieh YH; Chen WF; Huang JJ; Wu CW; Engel H; Cheng MH
    Plast Reconstr Surg; 2012 Jul; 130(1):64-72. PubMed ID: 22743874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of tolerance to composite tissue allograft in a rat model.
    Quatra F; Lowenberg DW; Buncke HJ; Romeo OM; Brooks D; Buntic RF; Baxter-Lowe LA
    Microsurgery; 2006; 26(8):573-8. PubMed ID: 17091475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
    Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance induction following allogeneic vascularized bone marrow transplantation--the possible role of microchimerism.
    Durlik M; Lukomska B; Religa P; Ziolkowska H; Namysłowski A; Janczewska S; Cybulska E; Soin J; Gaciong Z; Olszewski WL
    Transpl Int; 1998; 11 Suppl 1():S299-302. PubMed ID: 9665001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
    Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
    Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of combined immunosuppression with systemic low-dose cyclosporin and topical fluocinolone acetonide on the survival of rat hind-limb allografts.
    Inceoglu S; Siemionow M; Chick L; Craven CM; Lister GD
    Ann Plast Surg; 1994 Jul; 33(1):57-65. PubMed ID: 7944198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microchimerism following allogeneic vascularized bone marrow transplantation--its possible role in induction of posttransplantation tolerance.
    Durlik M; Lukomska B; Ziółkowska H; Namysłowski A; Janczewska S; Cybulska E; Olszewski WL
    Ann Transplant; 1998; 3(1):24-6. PubMed ID: 9869894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model.
    Prabhune KA; Gorantla VS; Perez-Abadia G; Francois CG; Vossen M; Laurentin-Perez LA; Breidenbach WC; Wang GG; Anderson GL; Pidwell DJ; Barker JH; Maldonado C
    Transplantation; 2003 Dec; 76(11):1548-55. PubMed ID: 14702522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor-derived transplant acceptance-inducing cells in composite tissue allotransplantation.
    Radu CA; Horn D; Kiefer J; Rebel M; Gebhard MM; Ryssel H; Köllensperger E; Fändrich F; Germann G; Kremer T
    J Plast Reconstr Aesthet Surg; 2012 Dec; 65(12):1684-91. PubMed ID: 22841770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
    Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
    Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.